[Featured Stock] Andyforce Surges on Mass Production of COVID-19 and Flu Simultaneous Diagnostic Kits

[Asia Economy Reporter Geum Bo-ryeong] AndyForce surged sharply on the afternoon of the 24th following news that it will mass-produce a kit that simultaneously diagnoses COVID-19 and influenza.

At 2:33 PM that day, AndyForce's stock price rose 11.65% (920 KRW) from the previous close to 8,820 KRW.

AndyForce announced that it began mass production of the "COVID-19 and Influenza Combo Diagnostic Kit" for overseas export on the same day. This kit can detect infections of COVID-19 as well as Influenza A and B at once.